Cargando…

Clinical and economic outcomes evaluated in Lyme disease: a systematic review

BACKGROUND: The financial implications of Lyme disease (LD) can vary widely for both the health system and the individual patients experiencing the disease. The aim of this review was to summarize published data on clinical and economic outcomes associated with LD. METHODS: A literature review was c...

Descripción completa

Detalles Bibliográficos
Autores principales: Mattingly, T. Joseph, Shere-Wolfe, Kalpana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346351/
https://www.ncbi.nlm.nih.gov/pubmed/32646476
http://dx.doi.org/10.1186/s13071-020-04214-y
_version_ 1783556390456918016
author Mattingly, T. Joseph
Shere-Wolfe, Kalpana
author_facet Mattingly, T. Joseph
Shere-Wolfe, Kalpana
author_sort Mattingly, T. Joseph
collection PubMed
description BACKGROUND: The financial implications of Lyme disease (LD) can vary widely for both the health system and the individual patients experiencing the disease. The aim of this review was to summarize published data on clinical and economic outcomes associated with LD. METHODS: A literature review was conducted to identify all studies of LD that incorporate both clinical outcomes and costs. Included studies were described and categorized based on costs consistent with best practices used in economic evaluation. RESULTS: The most frequent costs identified focused on formal health costs and productivity losses were the most common costs identified outside of the health system. Travel and informal care costs were less frequently reported. Clinical and economic outcomes of LD are primarily studied through economic models or observational analyses and focus on formal health care. CONCLUSIONS: This review provides and overview of existing evidence and recommendations for future economic analyses in LD. [Image: see text]
format Online
Article
Text
id pubmed-7346351
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73463512020-07-14 Clinical and economic outcomes evaluated in Lyme disease: a systematic review Mattingly, T. Joseph Shere-Wolfe, Kalpana Parasit Vectors Review BACKGROUND: The financial implications of Lyme disease (LD) can vary widely for both the health system and the individual patients experiencing the disease. The aim of this review was to summarize published data on clinical and economic outcomes associated with LD. METHODS: A literature review was conducted to identify all studies of LD that incorporate both clinical outcomes and costs. Included studies were described and categorized based on costs consistent with best practices used in economic evaluation. RESULTS: The most frequent costs identified focused on formal health costs and productivity losses were the most common costs identified outside of the health system. Travel and informal care costs were less frequently reported. Clinical and economic outcomes of LD are primarily studied through economic models or observational analyses and focus on formal health care. CONCLUSIONS: This review provides and overview of existing evidence and recommendations for future economic analyses in LD. [Image: see text] BioMed Central 2020-07-09 /pmc/articles/PMC7346351/ /pubmed/32646476 http://dx.doi.org/10.1186/s13071-020-04214-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Mattingly, T. Joseph
Shere-Wolfe, Kalpana
Clinical and economic outcomes evaluated in Lyme disease: a systematic review
title Clinical and economic outcomes evaluated in Lyme disease: a systematic review
title_full Clinical and economic outcomes evaluated in Lyme disease: a systematic review
title_fullStr Clinical and economic outcomes evaluated in Lyme disease: a systematic review
title_full_unstemmed Clinical and economic outcomes evaluated in Lyme disease: a systematic review
title_short Clinical and economic outcomes evaluated in Lyme disease: a systematic review
title_sort clinical and economic outcomes evaluated in lyme disease: a systematic review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346351/
https://www.ncbi.nlm.nih.gov/pubmed/32646476
http://dx.doi.org/10.1186/s13071-020-04214-y
work_keys_str_mv AT mattinglytjoseph clinicalandeconomicoutcomesevaluatedinlymediseaseasystematicreview
AT sherewolfekalpana clinicalandeconomicoutcomesevaluatedinlymediseaseasystematicreview